Presentation is loading. Please wait.

Presentation is loading. Please wait.

Combining Antiplatelet and Antithrombotic Therapy (Triple Therapy): What Are the Risks and Benefits?  Luis Alejandro Asencio, MD, Jennifer J. Huang, DO,

Published byTerence Washington Modified over 5 years ago

Similar presentations

Presentation on theme: "Combining Antiplatelet and Antithrombotic Therapy (Triple Therapy): What Are the Risks and Benefits?  Luis Alejandro Asencio, MD, Jennifer J. Huang, DO,"— Presentation transcript:

1 Combining Antiplatelet and Antithrombotic Therapy (Triple Therapy): What Are the Risks and Benefits? 
Luis Alejandro Asencio, MD, Jennifer J. Huang, DO, Joseph S. Alpert, MD  The American Journal of Medicine  Volume 127, Issue 7, Pages (July 2014) DOI: /j.amjmed Copyright © 2014 Elsevier Inc. Terms and Conditions

2 Figure 1 Cumulative risks for stroke with the 2 treatments (figure from the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events, reproduced with permission). RR = relative risk. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2014 Elsevier Inc. Terms and Conditions

3 Figure 2 Complications during 12-month follow-up with various drug regimens adopted after stenting in warfarin group. Reproduced and modified with permission from the study by Karjalainen et al.4 MI = myocardial infarction. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2014 Elsevier Inc. Terms and Conditions

Download ppt "Combining Antiplatelet and Antithrombotic Therapy (Triple Therapy): What Are the Risks and Benefits?  Luis Alejandro Asencio, MD, Jennifer J. Huang, DO,"

Similar presentations

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.
An Unusual Electrocardiogram in a Heart Transplant Recipient Hamish I. MacLachlan, BSc, MBBS, Jonathan R. Dalzell, MD, MRCP The American Journal of Medicine.

An Unusual Electrocardiogram in a Heart Transplant Recipient Hamish I. MacLachlan, BSc, MBBS, Jonathan R. Dalzell, MD, MRCP The American Journal of Medicine.
Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,
Usefulness of Outpatient Bleeding Risk Index to Predict Bleeding Complications in Patients With Long-term Oral Anticoagulation Undergoing Coronary Stenting 

Usefulness of Outpatient Bleeding Risk Index to Predict Bleeding Complications in Patients With Long-term Oral Anticoagulation Undergoing Coronary Stenting 
The Epidemic of the 20th Century: Coronary Heart Disease

The Epidemic of the 20th Century: Coronary Heart Disease
Anne B. Yates, MD  The American Journal of Medicine 

Anne B. Yates, MD  The American Journal of Medicine 
Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO 

Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO 
New-onset Atrial Fibrillation Predicts Heart Failure Progression

New-onset Atrial Fibrillation Predicts Heart Failure Progression
Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B

Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B
Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study  Torben Bjerregaard Larsen, MD,

Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study  Torben Bjerregaard Larsen, MD,
An Unusual Cause of Leg Ulcerations

An Unusual Cause of Leg Ulcerations
Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention  Chirag Bavishi, MD, MPH,

Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention  Chirag Bavishi, MD, MPH,
David D. McManus, MD, ScM, Wei Huang, MS, Kunal V

David D. McManus, MD, ScM, Wei Huang, MS, Kunal V
Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study  Torben Bjerregaard Larsen, MD,

Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study  Torben Bjerregaard Larsen, MD,
James H. Liu, MD  The American Journal of Medicine 

James H. Liu, MD  The American Journal of Medicine 
Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction  Stein Ørn, MD, John G.F. Cleland, MD, Matti.

Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction  Stein Ørn, MD, John G.F. Cleland, MD, Matti.
Introduction The American Journal of Medicine

Introduction The American Journal of Medicine
Matthew I. Worthley, MBBS, PhD, FRACP, Fiona M

Matthew I. Worthley, MBBS, PhD, FRACP, Fiona M
Systematic Review and Meta-analysis of Adverse Events of Low-dose Aspirin and Clopidogrel in Randomized Controlled Trials  Kenneth R. McQuaid, MD, Loren.

Systematic Review and Meta-analysis of Adverse Events of Low-dose Aspirin and Clopidogrel in Randomized Controlled Trials  Kenneth R. McQuaid, MD, Loren.
Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,

Similar presentations

Ads by Google